We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

128 hedge funds and large institutions have $358M invested in Lumos Pharma, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

242% more call options, than puts

Call options by funds: $49.1M | Put options by funds: $14.3M

147% more capital invested

Capital invested by funds: $145M → $358M (+$213M)

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

5% more funds holding

Funds holding: 122 → 128 (+6)

22% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 36

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
3.19%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
33
Increased
28
Reduced
36
Closed
18
Calls
$49.1M
Puts
$14.3M
Net Calls
+$34.7M
Net Calls Change
+$24.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$29.8M
2
DCM
Driehaus Capital Management
Illinois
+$3.38M
3
CCI
Columbus Circle Investors
+$3.31M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.16M
5
EI
EAM Investors
California
+$3.04M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$6.98M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.71M
3
BIM
Bogle Investment Management
Massachusetts
-$2.53M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.55M
5
TC
TFS Capital
Pennsylvania
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
26
Knoll Capital Management
Florida
$2.25M – – –
Barclays
27
Barclays
United Kingdom
$2.21M +$1.22M +8,540 +517%
Charles Schwab
28
Charles Schwab
California
$2.08M +$238K +1,664 +21%
Morgan Stanley
29
Morgan Stanley
New York
$2.08M -$608K -4,255 -31%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$2.08M +$352K +2,462 +35%
TAM
31
Tiverton Asset Management
Delaware
$2.05M – – –
VIA
32
Vident Investment Advisory
Georgia
$1.94M +$213K +1,493 +20%
Principal Financial Group
33
Principal Financial Group
Iowa
$1.67M – – –
RSCM
34
Rock Springs Capital Management
Maryland
$1.62M +$1.06M +7,452 New
Simplex Trading
35
Simplex Trading
Illinois
$1.54M +$799K +5,595 +367%
HT
36
HAP Trading
New York
$1.53M +$1.01M +7,039 New
Federated Hermes
37
Federated Hermes
Pennsylvania
$1.47M -$289K -2,025 -23%
ECM
38
Endurant Capital Management
California
$1.43M +$943K +6,605 New
NWM
39
Northwest Wealth Management
Iowa
$1.36M -$19K -133 -2%
JGC
40
J. Goldman & Co
New York
$1.33M +$873K +6,111 New
Citadel Advisors
41
Citadel Advisors
Florida
$1.26M +$828K +5,793 New
Renaissance Technologies
42
Renaissance Technologies
New York
$1.15M -$1.55M -10,878 -67%
PP
43
PDT Partners
New York
$1.07M -$98.4K -689 -12%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.03M -$31.7K -222 -4%
Russell Investments Group
45
Russell Investments Group
United Kingdom
$978K +$644K +4,508 New
IECM
46
Intrinsic Edge Capital Management
Illinois
$964K – – –
Point72 Asset Management
47
Point72 Asset Management
Connecticut
$964K +$635K +4,444 New
ARTA
48
A.R.T. Advisors
New York
$884K -$151K -1,056 -21%
Swiss National Bank
49
Swiss National Bank
Switzerland
$860K – – –
FIM
50
Freedom Investment Management
Connecticut
$791K -$61.7K -432 -11%
1
2
3 4 5

LUMO Hedge Fund Activity: Q1 2017 in Review

128 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2017, worth a combined $358M — up 147% from $145M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new LUMO positions and 18 closed out — a net gain of 15 holders — while 28 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $29.8M. The largest seller was Millennium Management, cutting an estimated $6.98M.

  • 128 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2017, up from 122 in Q4 2016.
  • Funds reported $358M of Lumos Pharma, Inc. Common Stock stock for Q1 2017, up 147% quarter-over-quarter.
  • 33 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2017 and 18 closed out, a net change of +15 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $29.8M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q1 2017 was Millennium Management, an estimated $6.98M sold.

Based on aggregated 13F filings for Q1 2017.